Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Expert Opin Drug Saf ; : 1-13, 2024 May 21.
Artigo em Inglês | MEDLINE | ID: mdl-38753437

RESUMO

BACKGROUND: Ranitidine induced tumor adverse events remains a contradictory clinical question, due to the limited evidence of tumor risk associated with ranitidine in the real world. The purpose of this study was to evaluate the association of ranitidine with all types of tumors through the FAERS database and to provide a reference for clinical use. RESEARCH DESIGN AND METHODS: Cancer cases associated with ranitidine in the FAERS database from the first quarter of 2004 to the fourth quarter of 2023 were extracted to analyze demographic characteristics, and a disproportion analysis was performed. RESULT: A total of 662,998 ranitidine-related cancer cases were screened, and the 50-59 and 60-69 groups accounted for the largest proportion. In PT signal detection, ranitidine was associated with 98 PT, including penal cancer stage II, gastric cancer stage II, et al. In terms of outcome events, adverse events were higher in men (20.65%) than in women (18.47%). CONCLUSIONS: Ranitidine may induce various tumor-related adverse reactions, especially in long-term users and elderly patients. For these patients, tumor screening should be strengthened, and long-term use of ranitidine should be avoided. Since this study cannot prove causality, further evidence is needed for prospective studies with a larger sample size.

2.
Nanomedicine (Lond) ; 13(18): 2301-2310, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-30284477

RESUMO

AIMS: miRNAs are regarded as potential biomarkers correlated with the development and progression of many diseases. However, it is a challenge to construct a sensitive method to detect them without using time-consuming radioactive labeling or complex amplification strategies. METHODS: A facile resonance light scattering (RLS) system was developed for the detection of miRNA employing magnetic nanoparticles (MNPs) as RLS probes. MNPs were coated with streptavidin. DNA probes were modified on the surface of MNPs based on the specific interaction of streptavidin and biotin forming MNPs@DNA probes. MNPs@DNA probes dispersed in homogeneous media causing low RLS signal. RESULTS & CONCLUSION: miRNA hybridized with DNA probes resulting in the aggregation of MNPs and inducing the enhancement of RLS intensity. miRNAs were determined successfully with limit of detection at 0.9 picomole per liter (pM). The potential clinical application of the present biosensor was also demonstrated by measuring miRNAs in human normal and cancer cells, and human serum samples.


Assuntos
Bioensaio/métodos , Técnicas Biossensoriais/métodos , Nanopartículas de Magnetita/química , MicroRNAs/análise , Células A549 , Biotina/química , Sondas de DNA/química , Difusão Dinâmica da Luz , Humanos , Células MCF-7 , MicroRNAs/genética , Microscopia Eletrônica de Transmissão , Estreptavidina/química
3.
Am J Physiol Cell Physiol ; 283(2): C552-9, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12107065

RESUMO

Angiotensin (ANG) II receptors have been reported in the nonpigmented ciliary epithelium (NPE) of the eye. In cultured NPE, we found ANG II caused a dose-dependent rise of cytoplasmic sodium. The sodium increase was inhibited by the AT(1)-AT(2) receptor antagonist saralasin (IC(50) = 3.7 nM) and the AT(1) antagonist losartan (IC(50) = 0.6 nM) but not by the AT(2) antagonist PD-123319. ANG II also caused a dose-dependent increase in the rate of ouabain-sensitive (86)Rb uptake. The ANG II-induced cell sodium increase and (86)Rb uptake increase were reduced by dimethylamiloride (DMA; 10 microM). On the basis of this finding, we propose that Na(+)/H(+) exchange is stimulated by ANG II. Simultaneously, ANG II appears to inhibit H(+)-ATPase-mediated proton export. Thus Ang II (10 nM) did not alter the baseline cytoplasmic pH (pH(i)) but reduced pH(i) in cells that were also exposed to 10 microM DMA. Consistent with the notion of H(+)-ATPase inhibition in ANG II-treated NPE, bafilomycin A(1) (100 nM) (BAF) and ANG II were both observed to suppress the pH(i) increase that occurs upon exposure to a mixture of epinephrine (1 microM) and acetylcholine (10 microM) and the pH(i) increase elicited by depolarization. In ATP hydrolysis measurements, H(+)-ATPase activity (bafilomycin A(1)-sensitive ATP hydrolysis) was reduced significantly in cells that had been pretreated 10 min with 10 nM ANG II. In summary, these studies suggest that ANG II causes H(+)-ATPase inhibition and an increase of cell sodium due to activation of Na(+)/H(+) exchange.


Assuntos
Angiotensina II/farmacologia , Corpo Ciliar/metabolismo , Citoplasma/metabolismo , Macrolídeos , Sódio/metabolismo , Amilorida/análogos & derivados , Amilorida/farmacologia , Animais , Antibacterianos/farmacologia , Células Cultivadas , Corpo Ciliar/citologia , Inibidores Enzimáticos/farmacologia , Células Epiteliais/metabolismo , Concentração de Íons de Hidrogênio , Concentração Osmolar , ATPases Translocadoras de Prótons/antagonistas & inibidores , Coelhos , Trocador de Sódio e Cálcio/antagonistas & inibidores , ATPase Trocadora de Sódio-Potássio/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA